share_log
Moomoo 24/7 ·  2023/11/07 07:17

ADC Therapeutics Sees Continued Decrease In Total Operating Expenses In FY23 And FY24 As Compared to FY22; Expected Cash Runway Into Middle of 2025

ADC Therapeutics預計,與22財年相比,23財年和24財年的總運營支出將繼續減少;預計現金流將持續到2025年中期

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論